Anand Kumar Rohatgi MD MSCS, FACC, FAHA
Preventive Cardiology
Professor of Medicine / Preventive Cardiology / Cardiovascular Disease Fellowship Assistant Program Director of Academic Development
Join to View Full Profile
5323 Harry Hines BoulevardDallas, TX 75390
Phone+1 469-647-4445
Fax+1 469-497-2671
Dr. Rohatgi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas Southwestern Medical CenterFellowship, Cardiovascular Disease, 2005 - 2008
University of Pennsylvania Health SystemResidency, Internal Medicine, 2002 - 2005
Duke University School of MedicineClass of 2002
Certifications & Licensure
TX State Medical License 2007 - 2026
PA State Medical License 2002 - 2008
American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2011, 2013-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2011, 2013-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
Clinical Trials
- Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus Start of enrollment: 2010 Jun 18
- A Study of Evacetrapib in High-Risk Vascular Disease Start of enrollment: 2012 Oct 01
- The Genetic, Protein, and Lipid Basis of Variation in Cholesterol Efflux Start of enrollment: 2017 Dec 01
Publications & Presentations
PubMed
- Clinician-level variation in lipid management for secondary prevention of atherosclerotic cardiovascular disease: Opportunities for practice improvement.Danh Q Nguyen, Jimin Hwang, Anand Rohatgi, Parag H Joshi, Amit Khera
American Journal of Preventive Cardiology. 2026-04-01 - Characterization and response to exercise training of HDL-specific phospholipid efflux.Eric C Leszczynski, Charles S Schwartz, Kiani J C Jacobs, Prasun K Dev, Sujoy Ghosh
Journal of Lipid Research. 2026-02-03 - Cardiovascular Testing and Changes in Lipid-Lowering Therapy After Coronary Artery Calcium Scoring.Willis Y Wong, Luyu Xie, Pamela Chan, Danh Q Nguyen, Parag H Joshi
JACC. Advances. 2026-02-01
Journal Articles
- Value of Coronary Artery Calcium Scanning in Association with the Net Benefit of Aspirin in Primary Prevention of Atherosclerotic Cardiovascular DiseaseEzimamaka Ajufo, Anand Rohatgi, JAMA Cardiology
Press Mentions
Guidelines Target High Cardiometabolic Risk Among South AsiansJune 2nd, 2025- ‘Good’ Cholesterol May Protect Against Brain Atrophy, DementiaJanuary 2nd, 2025
- SAHELI: Do Culturally Adapted Lifestyle Intervention Improve CVD Risk Factors?September 26th, 2024
Grant Support
- Mentoring Patient-Oriented Research in Deep Lipid Phenotyping for Cardiovascular DiseaseUT SOUTHWESTERN MEDICAL CENTER2019–2029
- Lipoprotein Metabolism and Excess Cardiometabolic Risk in South AsiansUT SOUTHWESTERN MEDICAL CENTER2022–2027
- The Genetic and Molecular Basis of Cholesterol EffluxNIH/NHLBI2018–2023
Professional Memberships
- Fellow
- Fellow
External Links
- Rohatgi Labhttps://www.utsouthwestern.edu/labs/rohatgi/
- Clinical Profilehttps://utswmed.org/doctors/anand-rohatgi/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
